Literature DB >> 10757806

Stress signals utilize multiple pathways to stabilize p53.

M Ashcroft1, Y Taya, K H Vousden.   

Abstract

The p53 tumor suppressor is activated by many diverse stress signals through mechanisms that result in stabilization and accumulation of the p53 protein. p53 is normally degraded through the proteasome following interaction with MDM2, which both functions as a ubiquitin ligase for p53 and shuttles to the cytoplasm, where p53 degradation occurs. Stabilization of p53 in response to stress is associated with inhibition of MDM2-mediated degradation, which has been associated with phosphorylation of p53 in response to DNA damage or activation of ARF. In this study we show distinct responses, as measured by phosphorylation, transcriptional activity, and subcellular localization, of p53 stabilized by different activating signals. Although normal cells and wild-type p53-expressing tumor cells showed similar responses to actinomycin D and camptothecin treatment, the transcriptional activity of stabilized p53 induced by deferoxamine mesylate, which mimics hypoxia, in normal cells was lost in all three tumor cell lines tested. Our results show that multiple pathways exist to stabilize p53 in response to different forms of stress, and they may involve down-regulation of MDM2 expression or regulation of the subcellular localization of p53 or MDM2. Loss of any one of these pathways may predispose cells to malignant transformation, although reactivation of p53 might be achieved through alternative pathways that remain functional in these tumor cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10757806      PMCID: PMC85616          DOI: 10.1128/MCB.20.9.3224-3233.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs.

Authors:  S Laín; C Midgley; A Sparks; E B Lane; D P Lane
Journal:  Exp Cell Res       Date:  1999-05-01       Impact factor: 3.905

2.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.

Authors:  T Unger; T Juven-Gershon; E Moallem; M Berger; R Vogt Sionov; G Lozano; M Oren; Y Haupt
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

3.  Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53.

Authors:  C Blattner; A Sparks; D Lane
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.

Authors:  S Y Shieh; Y Taya; C Prives
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.

Authors:  W Tao; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.

Authors:  Y Zhang; Y Xiong
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

7.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.

Authors:  R Montes de Oca Luna; D S Wagner; G Lozano
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

8.  p21 is necessary for the p53-mediated G1 arrest in human cancer cells.

Authors:  T Waldman; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

9.  Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.

Authors:  C Deng; P Zhang; J W Harper; S J Elledge; P Leder
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

10.  Radiation-induced cell cycle arrest compromised by p21 deficiency.

Authors:  J Brugarolas; C Chandrasekaran; J I Gordon; D Beach; T Jacks; G J Hannon
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

View more
  131 in total

Review 1.  DNA replication blockade impairs p53-transactivation.

Authors:  R Takimoto; W S El-Deiry
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  p53 down-regulates CHK1 through p21 and the retinoblastoma protein.

Authors:  V Gottifredi; O Karni-Schmidt; S S Shieh; C Prives
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

4.  Chaperoning of mutant p53 protein by wild-type p53 protein causes hypoxic tumor regression.

Authors:  Rajan Gogna; Esha Madan; Periannan Kuppusamy; Uttam Pati
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

5.  Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.

Authors:  Jayne M Stommel; Geoffrey M Wahl
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

6.  Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.

Authors:  Xiao-Xin Sun; Yue-Gang Wang; Dimitris P Xirodimas; Mu-Shui Dai
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

7.  Atypical mouse cerebellar development is caused by ectopic expression of the forkhead box transcription factor HNF-3beta.

Authors:  H Zhou; D E Hughes; M L Major; K Yoo; C Pesold; R H Costa
Journal:  Gene Expr       Date:  2001

8.  Nrf2, a guardian of healthspan and gatekeeper of species longevity.

Authors:  Kaitlyn N Lewis; James Mele; John D Hayes; Rochelle Buffenstein
Journal:  Integr Comp Biol       Date:  2010-05-06       Impact factor: 3.326

9.  Cloning and characterization of the human gene DERP6, which activates transcriptional activities of p53.

Authors:  Jian Yuan; Wenwen Tang; Kuntian Luo; Xinya Chen; Xiuting Gu; Bo Wan; Long Yu
Journal:  Mol Biol Rep       Date:  2006-09       Impact factor: 2.316

10.  Balanced production of ribosome components is required for proper G1/S transition in Saccharomyces cerevisiae.

Authors:  Fernando Gómez-Herreros; Olga Rodríguez-Galán; Macarena Morillo-Huesca; Douglas Maya; María Arista-Romero; Jesús de la Cruz; Sebastián Chávez; Mari Cruz Muñoz-Centeno
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.